Download presentation
Presentation is loading. Please wait.
1
Arthritis Osteoarthritis (OA)
Most common form of joint (articular) disease Previously called degenerative joint disease Risk Factor: growing older Not considered a normal part of the aging process 90% of adults are affected by age 40 Few patients show symptoms after age 60 60% of patients > 65 years show signs & symptoms Greater in women than men Family history
2
Osteoarthritis (OA) Etiology & Pathophysiology
Idiopathic (primary) Cause – unknown Secondary Trauma / Mechanical stress Overused joints from work or sports related activities Inflammation Joint instability Neurologic disorders Skeletal deformities Side Effects of Medications Weakened immune system Chronic illness such as diabetes, cancer or liver disease Infections such as Lyme disease. Risk Factor: Obesity
3
Osteoarthritis (OA) Etiology & Pathophysiology
Cartilage damages that triggers a metabolic response Progressive degeneration—cartilage becomes softer, less elastic, and less able to resist wear and heavy use Body’s attempt cannot keep up with destruction Cartilage erodes at the articular surfaces Cartilage thins; bony growth increases at joint margins Incongruity in joint surfaces Uneven distribution of stress across the joint Reduction in motion Inflammation is not a characteristic of OA
5
Osteoarthritis Etiology & Pathophysiology
7
Osteoarthritis Clinical Manifestations
Systemic: None Joints: mild discomfort to significant disability In early disease- joint pain increasing with use Relieved by rest In advanced disease – joint stiffness and pain after rest “early morning stiffness” Resolved within 30 minutes after movement Overuse – joint effusion Crepitation – grating sensation caused by loose particles – contributes to stiffness
8
Osteoarthritis Most Involved Joints
9
Osteoarthritis Etiology & Pathophysiology
Affects joints asymmetrically Most commonly involved joints: Distal interphalangeal (DIP) Proximal interphalangeal (PIP) Carpometacarpal joint of the thumb Weight-bearing joints (hips, knees) Metatarsophalangeal (MTP) joint of the foot Cervical and lumbar vertebrae
10
Osteoarthritis Etiology & Pathophysiology
Deformity Specific to the involved joint Herberden’s nodes – DIP joints Bouchard’s nodes – PIP joints Both are red, edematous, tender-painful Do not usually cause loss of function
11
Osteoarthritis Diagnostic Studies
Bone Scan CT MRI General x-ray Radiologic changes do not correlate with the degree of disease
12
Osteoarthritis Treatment Goals
No cure Focus: Managing pain Preventing disability Maintaining and improving joint function
13
Osteoarthritis Treatment Goals
Rest and Joint Protection Balance of rest and activity Assistive devices Heat and Cold Applications Hot packs, whirlpools, ultrasound, paraffin wax baths, pool therapy Nutritional Therapy & Exercise Weight reduction – Goal: decrease load on the joints & increase joint mobilization
14
Osteoarthritis - Tx Goals
Drug Therapy Tylenol – up to 1000 mg q6h Aspirin Nonsteroidal anti-inflammatory drugs Motrin (OTC) 200 mg qid++ Traditional NSAID – decrease platelet aggregation – prolong bleeding time Newer generation – Cox inhibitors (cyclooxygenase) e.g., Celebrex Intraarticular injections—knees; shoulder Intraforamenal-intervertebral Injections – vertebral Corticosteroids – decrease local inflammation & effusion Hyaluronic Acid – increased production of synovial fluid – Hyalgan, Synvisc
15
Osteoarthritis Treatment Goals
Surgical Treatment Joint Replacement Hip, Knee, Shoulder Spinal Surgery – Diskectomy /spinal fusion
18
Spine Surgery for Arthritis
The Spine Spine Surgery for Arthritis
19
Degenerative Disc Disease
20
Lumbar Spinal Stenosis
21
Osteoarthritis Nursing Diagnoses
Acute & Chronic Pain r/t physical activity Disturbed sleeping pattern Impaired physical mobility Self-care deficits r/t joint deformity & pain Imbalanced nutrition Chronic low self-esteem r/t changing physical appearance
22
Osteoarthritis Nursing Management Goals
Maintain or improve joint function through balance of rest and activity Joint protection measures to improve activity tolerance Maintain independence and self-care Use drug therapy safely to manage pain without side effects REHABILITATION
23
Rheumatoid Arthritis (RA)
Chronic, systemic disease Inflammation of connective tissue in the diarthrodial (synovial) joint Periods of remissions & exacerbation Extraarticular manifestations
24
Rheumatoid Arthritis (RA) Etiology & Pathophysiology
Cause – unknown Autoimmune – most widely accepted theory Antigen/abnormal Immunoglobulin G (IgG) Presence of autoantibodies – rheumatoid factor IgG + rheumatoid factor form deposits on synovial membranes & articular cartilage Inflammation results – pannus (granulation tissue at the joint margins) – articular cartilage destruction Genetic – predisposition/familial occurrence of “human leukocyte antigen (HLA) in white RA patients
25
Rheumatoid Arthritis
26
Osteoarthritis Rheumatoid Arthritis
28
Rheumatoid Arthritis Anatomic 4 Stages
Stage 1 – Early No destructive changes on x-ray; possible osteoporosis Stage II – Moderate X-ray osteoporosis; no joint deformities; possible presence f extraarticuloar soft tissue lesions Stage III – Severe X-ray evidence of cartilage and bone destruction in addition to osteoporosis; joint deformity—subluxation, ulnar deviation, hyperextension, bony ankylosis; muscle atrophy, soft tissue lesions Stage IV – Terminal Fibrous or bony ankylosis; criteria of Stage III
29
Rheumatoid Arthritis Clinical Manifestations
Insidious – fatigue, anorexia, weight loss, generalized stiffness Joints Stiffness becomes localized—pain, edema, limited motion, inflammation, joints warm to touch, fingers—spindle shaped “Morning Stiffness” – 60+ mins to several hours depending on disease progression
30
Rheumatoid Arthritis Clinical Manifestations
Extraarticular Manifestations Sjorgren Syndrome – decreased lacrimal secretion—burning, gritty, itchy eyes with decreased tearing and photosensitivity Valvular lesions/pericarditis Interstitial fibrosis / pleuritis Lymphadenopathy Raynaud’s Phenomenon Peripheral neuropathy & edema Myositis
31
Rheumatoid Arthritis Clinical Manifestations
32
Rheumatoid Arthritis Diagnostic Studies
Lab Studies Rheumatoid Factor – 80% of patients ESR C-Reactive Protein WBC up to 25,000/ul Synovial biopsy – inflammation Bone Scan
33
Rheumatoid Arthritis Treatment Goals
Drug Therapy NSAIDs Disease-modifying antirheumatic drugs (DMARDS) - Anti-inflammatory action Mild Disease – Plaquenil (antimalarial drug) Moderate – Severe Disease -- Methotrexate Severe Disease - Gold Therapy (weekly injections x 5 months) Corticosteroid Therapy Nutrition – balanced diet
34
Rheumatoid Arthritis Nursing Diagnoses
Chronic pain r/t joint inflammation Impaired physical mobility Disturbed body image r/t chronic disease Ineffective therapy regimen management r/t complexity of chronic health problem Self-care deficit r/t disease progression
35
Rheumatoid Arthritis Nursing Management Goals
Satisfactory pain relief Minimal loss of functional ability of affected joints Patient participation in planning and carrying out therapeutic regimen Positive-self image Self-care to the maximum capability
37
Rheumatoid Arthritis Rest alternating with activity as tolerated -- Energy conservation Joint protection Time-saving joint protective devices Heat / Cold Therapy – relieve stiffness, pain, and muscle spasm Exercise –individualized –Aquatic Therapy Psychological Therapy – individual & family support system
38
Arthritis Gerontologic Considerations
Sensitivity to medication NSAIDs – GI Bleed Corticosteroid therapy – osteopenia adds to inactivity-related loss of bone density Pathological fractures Challenges to Self-Care & Decisions Autonomous Assisted Living
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.